“conformations, or fit. Thus the rationale for structure-based design: to optimize the shapes of drug molecules. “Connecting the dots,” Aldrich liked to call it in a heroic oversimplification that made some of the scientists at the tables wince. In effect, the goal is the very opposite of screening: building the molecules one wants rather than fishing for approximations in nature. The advantages of such drugs presumably”